Mesrouze Yannick, Bokhovchuk Fedir, Meyerhofer Marco, Fontana Patrizia, Zimmermann Catherine, Martin Typhaine, Delaunay Clara, Erdmann Dirk, Schmelzle Tobias, Chène Patrick
Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Elife. 2017 Apr 21;6:e25068. doi: 10.7554/eLife.25068.
TEAD (/ATTS omain) transcription factors are the most distal effectors of the Hippo pathway. YAP (es-ssociated rotein) is a coactivator protein which, upon binding to TEAD proteins, stimulates their transcriptional activity. Since the Hippo pathway is deregulated in various cancers, designing inhibitors of the YAP:TEAD interaction is an attractive therapeutic strategy for oncology. Understanding the molecular events that take place at the YAP:TEAD interface is therefore important not only to devise drug discovery approaches, but also to gain knowledge on TEAD regulation. In this report, combining single site-directed mutagenesis and double mutant analyses, we conduct a detailed analysis on the role of several residues located at the YAP:TEAD interface. Our results provide quantitative understanding of the interactions taking place at the YAP:TEAD interface and give insights into the formation of the YAP:TEAD complex and more particularly on the interaction between TEAD and the Ω-loop found in YAP.
TEAD(/ATTS结构域)转录因子是Hippo信号通路的最下游效应器。YAP(Yes相关蛋白)是一种共激活蛋白,它与TEAD蛋白结合后会刺激其转录活性。由于Hippo信号通路在多种癌症中失调,设计YAP:TEAD相互作用的抑制剂是一种有吸引力的肿瘤治疗策略。因此,了解YAP:TEAD界面发生的分子事件不仅对于设计药物发现方法很重要,而且对于了解TEAD调控也很重要。在本报告中,我们结合单点定向诱变和双突变分析,对位于YAP:TEAD界面的几个残基的作用进行了详细分析。我们的结果提供了对YAP:TEAD界面发生的相互作用的定量理解,并深入了解了YAP:TEAD复合物的形成,尤其是TEAD与YAP中发现的Ω环之间的相互作用。